Bonvehí, P., Boutriau, D., Casellas, J., Weynants, V., Feron, C., & Poolman, J. (2010). Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults. American Society for Microbiology (ASM).

Bonvehí, Pablo, Dominique Boutriau, Javier Casellas, Vincent Weynants, Christiane Feron, and Jan Poolman. Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults. American Society for Microbiology (ASM), 2010.

Bonvehí, Pablo, et al. Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults. American Society for Microbiology (ASM), 2010.